In focus · trending topic

proqr

54 stories · following the connections

ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB

By Nasdaq OMXApr 30, 2018, 11:00 AM UTC

ProQR Provides Enrollment Update on QR-110 Clinical Trial and Highlights Ophthalmology Presentations at ARVO

By Nasdaq OMXApr 23, 2018, 11:00 AM UTC

ProQR Announces Annual Meeting of Shareholders

By Nasdaq OMXApr 11, 2018, 11:00 AM UTC

ProQR Appoints ADAR Expert Dr. Peter A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology

By Nasdaq OMXApr 10, 2018, 11:00 AM UTC

ProQR to Present at Upcoming Investor Conference

By Nasdaq OMXMar 5, 2018, 12:01 PM UTC

Foundation Fighting Blindness will provide up to $7.5 million in funding to develop ProQR’s candidate QR-421a for Usher syndrome type 2A

By Nasdaq OMXFeb 12, 2018, 12:01 PM UTC

ProQR to Present at Upcoming Scientific Meeting and Investor Conference

By Nasdaq OMXFeb 6, 2018, 12:00 PM UTC

ProQR and Galapagos Announce Research Collaboration on Fibrosis Targets Using ProQR’s Axiomer® technology

By Nasdaq OMXJan 8, 2018, 12:01 PM UTC